Professional Bio
Dr. Tompkins joined the faculty at the University of Rochester after completing her cardiology and electrophysiology training at Johns Hopkins in Baltimore. She provides comprehensive inpatient and outpatient care of cardiac arrhythmias. Her primary research interest is in the management of ventricular arrhythmias that lead to sudden cardiac death. She is currently enrolling patients in registries to assess outcomes following catheter ablation of ventricular arrhythmias and atrial fibrillation.
2011
Tompkins, C.; Henrikson C. A. "Optimal strategies for the management of antiplatelet and anticoagulation medications prior to cardiac device implantation." Cardiology Journal. 2011; 18(1): 103-109. |
2011
Tompkins C.; McLean R.; Cheng A.; Brinker J.A.; Marine J.E.; Nazarian S.; Spragg D.D.; Sinha S.; Halperin H.; Tomaselli G.F.; Berger R.D.; Calkins H.; Henrikson C.A. "End-Stage Renal Disease Predicts Complications in Pacemaker and ICD Implants." Journal of Cardiovascular Electrophysiology. 2011; Epub ahead of print. |
2011
Cheng A.; Nazarian S.; Brinker J.A.; Tompkins C.; Spragg D.D.; Leng C.T.; Halperin H.; Tandri H.; Sinha S.K.; Marine J.E.; Calkins H.; Tomaselli G.F.; Berger R.D.; Henrikson C.A. "Continuation of warfarin during pacemaker or implantable cardioverter-defibrillator implantation: a randomized clinical trial." Heart Rhythm. 2011; 8(4): 536-540. |
2010 May
Tompkins CM, Cheng A, Dalal D, Brinker JA, Leng CT, Marine JE, Nazarian S, Spragg DD, Sinha S, Halperin H, Tomaselli GF, Berger RD, Calkins H, Henrikson CA. Johns Hopkins Hospital, Baltimore, MD. "Dual antiplatelet therapy and heparin "bridging" significantly increase the risk of bleeding following device implantation." Journal of the American College of Cardiology. 2010; 55(21): 2376-2382. |
2009
Majmudar M, Tompkins CM, Bachmann, JM, Blumenthal RS, Marine JE. "Effects of Lipid-Altering Therapies on Ventricular Arrhythmias and Sudden Cardiac Death." Cardiology in Review.. 2009; 17(2): 60-69. |
